All Journals > The Journal of Infectious Diseases > 1 January 2006 > Effect of HIV‐1 on Antimalarial Treatment

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

1 January 2006

Volume 193, Number 1
The Journal of Infectious Diseases 2006;193:9–15
0022-1899/2006/19301-0004$15.00
DOI: 10.1086/498577
MAJOR ARTICLE

Effect of HIV‐1 Infection on Antimalarial Treatment Outcomes in Uganda: A Population‐Based Study

Moses R. Kamya,1

Anne F. Gasasira,1

Adoke Yeka,2

Nathan Bakyaita,2

Samuel L. Nsobya,1

Damon Francis,3

Philip J. Rosenthal,3

Grant Dorsey,3 and

Diane Havlir3

1Department of Medicine, Makerere University Medical School, and 2Ministry of Health, Kampala, Uganda; 3Department of Medicine, San Francisco General Hospital, University of California, San Francisco

Background.Human immunodeficiency virus (HIV) infection may increase the burden of malaria by increasing susceptibility to infection or by decreasing the response to antimalarial treatment. We investigated the seroprevalence rate of HIV‐1 infection and its effect on antimalarial treatment outcomes in adults and children with uncomplicated falciparum malaria in Uganda.

Methods.This retrospective study included 1965 patients 18 months old who were randomized to receive 1 of 3 antimalarial regimens at 7 sites in Uganda. HIV‐1 testing was performed using 2 enzyme‐linked immunosorbent assays and Western blot analysis of stored blood spots. The primary study outcome was clinical treatment failure at 28 days after antimalarial treatment. Molecular genotyping was used to distinguish clinical treatment failures due to new infections from those due to recrudescences.

Results.The HIV‐1 seroprevalence rate was 2.5% in 1802 patients <18 years old and 31% in 163 patients 18 years old presenting with malaria. HIV‐1 infection was associated with a >3‐fold (hazard ratio [HR], 3.28 [95% confidence interval {CI}, 1.25–8.59]) increased risk of clinical treatment failure for adults, but there was no increased risk for HIV‐1–infected children. Molecular genotyping revealed that clinical treatment failures were due to new infections (HR, 6.35 [95% CI, 1.64–24.5]) rather than to recrudescences (HR, 1.51 [95% CI, 0.27–8.58]).

Conclusions.The HIV‐1 seroprevalence rate was surprisingly high in adults presenting with malaria. This finding supports the implementation of routine HIV counseling and testing for adults with uncomplicated falciparum malaria. HIV‐1 infection increased the susceptibility to new malarial infections but did not increase the risk of recrudescences in adults.

Received 31 May 2005; accepted 27 July 2005; electronically published 18 November 2005.

Reprints or correspondence: Dr. Moses R. Kamya, Dept. of Medicine, Makerere University, P.O. Box 7072, Kampala, Uganda ().

Cited by

Jane Achan, Anne F Gasasira, Fran Aweeka, Diane Havlir, Philip J Rosenthal, Moses R Kamya. (2008) Prophylaxis and treatment of malaria in HIV-infected populations. Future HIV Therapy 2:5, 453-464
Online publication date: 1-Oct-2008.
CrossRef
S. TELFER, R. BIRTLES, M. BENNETT, X. LAMBIN, S. PATERSON, M. BEGON. (2008) Parasite interactions in natural populations: insights from longitudinal data. Parasitology 135:07,
Online publication date: 1-Jul-2008.
CrossRef
Anne F. Gasasira, Moses R. Kamya, Jane Achan, Tsedal Mebrahtu, Joan N. Kalyango, Theodore Ruel, Edwin Charlebois, Sarah G. Staedke, Adeodata Kekitiinwa, Philip J. Rosenthal, Diane Havlir, and Grant Dorsey. (2008) High Risk of Neutropenia in HIV‐Infected Children following Treatment with Artesunate plus Amodiaquine for Uncomplicated Malaria in Uganda. Clinical Infectious Diseases 46:7, 985-991
Online publication date: 1-Apr-2008.
S. J. ROGERSON, P. BOEUF. (2008) New approaches to pathogenesis of malaria in pregnancy. Parasitology 134:13,
Online publication date: 1-Jan-2008.
CrossRef
Lisa M Bebell, Anne Gasasira, Moses Kiggundu, Christian Dokomajilar, Moses R Kamya, Edwin D Charlebois, Diane Havlir, Philip J Rosenthal, Grant Dorsey. (2008) HIV-1 Infection in Patients Referred for Malaria Blood Smears at Government Health Clinics in Uganda. JAIDS Journal of Acquired Immune Deficiency Syndromes 46:5, 624-630
Online publication date: 1-Jan-2008.
CrossRef
Christopher L. Karp and Paul G. Auwaerter. (2007) HIV/AIDS: Coinfection with HIV and Tropical Infectious Diseases. I. Protozoal Pathogens. Clinical Infectious Diseases 45:9, 1208-1213
Online publication date: 1-Nov-2007.
Devon D Brewer, David Gisselquist, Stuart Brody, John J Potterat. (2007) Investigating Iatrogenic HIV Transmission in Ugandan Children. JAIDS Journal of Acquired Immune Deficiency Syndromes 45:2, 253-254
Online publication date: 1-Jul-2007.
CrossRef
Laurence Slutsker, Barbara J Marston. (2007) HIV and malaria: interactions and implications. Current Opinion in Infectious Diseases 20:1, 3???10
Online publication date: 1-Mar-2007.
CrossRef
Miriam K. Laufer, Christopher V. Plowe. (2007) The interaction between HIV and malaria in Africa. Current Infectious Disease Reports 9:1, 47-54
Online publication date: 1-Feb-2007.
CrossRef
Snehal N. Shah, Ernest E. Smith, Charles O. Obonyo, Kevin C. Kain, Peter B. Bloland, Laurence Slutsker, and Mary J. Hamel. (2006) HIV Immunosuppression and Antimalarial Efficacy: Sulfadoxine‐Pyrimethamine for the Treatment of Uncomplicated Malaria in HIV‐Infected Adults in Siaya, Kenya. The Journal of Infectious Diseases 194:11, 1519-1528
Online publication date: 1-Dec-2006.
Kirsten Hewitt, Richard Steketee, Victor Mwapasa, Jimmy Whitworth, Neil French. (2006) Interactions between HIV and malaria in non-pregnant adults: evidence and implications. AIDS 20:16, 1993???2004
Online publication date: 1-Nov-2006.
CrossRef
Anne E McCarthy, Maria D Mileno. (2006) Prevention and treatment of travel-related infections in compromised hosts. Current Opinion in Infectious Diseases 19:5, 450???455
Online publication date: 1-Nov-2006.
CrossRef
Jean‐Pierre Van geertruyden, Modest Mulenga, Lawrence Mwananyanda, Victor Chalwe, Filip Moerman, Roma Chilengi, Webster Kasongo, Chantal Van Overmeir, Jean‐Claude Dujardin, Robert Colebunders, Luc Kestens, and Umberto D’Alessandro. (2006) HIV‐1 Immune Suppression and Antimalarial Treatment Outcome in Zambian Adults with Uncomplicated Malaria. The Journal of Infectious Diseases 194:7, 917-925
Online publication date: 1-Oct-2006.
L. RENIA, S. M. POTTER. (2006) Co-infection of malaria with HIV: an immunological perspective. Parasite Immunology 0:0, 060706013007005-???
Online publication date: 6-Aug-2006.
CrossRef
James G. Kublin and Richard W. Steketee. (2006) HIV Infection and Malaria—Understanding the Interactions. The Journal of Infectious Diseases 193:1, 1-3
Online publication date: 1-Jan-2006.
  • Financial support: Centers for Disease Control and Prevention/Association of Schools of Public Health cooperative agreement “Malaria Surveillance and Control in Uganda” (grants SA3569 and S1932‐21/21); Department for International Development; National Institutes of Health (grant K24‐AI51982 to D.H.).

    Potential conflicts of interest: none reported.

Close Popup